These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37241204)

  • 1. Laser Devices and Autologous Platelet Concentrates in Prevention and Treatment of Medication-Related Osteonecrosis of the Jaws: A Systematic Review.
    Scribante A; Ghizzoni M; Pellegrini M; Pulicari F; Spadari F
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241204
    [No Abstract]   [Full Text] [Related]  

  • 2. The effectiveness of autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: A systematic review.
    Nowak SM; Sacco R; Mitchell FL; Patel V; Gurzawska-Comis K
    J Craniomaxillofac Surg; 2024 Jun; 52(6):671-691. PubMed ID: 38644092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review.
    Fortunato L; Bennardo F; Buffone C; Giudice A
    J Craniomaxillofac Surg; 2020 Mar; 48(3):268-285. PubMed ID: 32063481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for managing medication-related osteonecrosis of the jaw.
    Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous platelet concentrates in treatment of medication related osteonecrosis of the jaw.
    Rusilas H; Balčiūnaitė A; Žilinskas J
    Stomatologija; 2020; 22(1):23-27. PubMed ID: 32706343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses.
    Karna H; Gonzalez J; Radia HS; Sedghizadeh PP; Enciso R
    Oral Oncol; 2018 Oct; 85():15-23. PubMed ID: 30220314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of complementary treatment with autologous platelet concentrates and/or mesenchymal stem cells in chemical osteonecrosis of the jaw. Systematic review of the literature.
    Escobedo MF; Junquera S; Gonzalez C; Vasatyuk S; Gallego L; Barbeito E; Junquera LM
    J Stomatol Oral Maxillofac Surg; 2022 Feb; 123(1):51-58. PubMed ID: 33609789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial photodynamic and photobiomodulation adjuvant therapies for prevention and treatment of medication-related osteonecrosis of the jaws: Case series and long-term follow-up.
    Tartaroti NC; Marques MM; Naclério-Homem MDG; Migliorati CA; Zindel Deboni MC
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101651. PubMed ID: 31923636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review.
    Lopez-Jornet P; Sanchez Perez A; Amaral Mendes R; Tobias A
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1067-72. PubMed ID: 27318752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).
    Nica DF; Riviș M; Roi CI; Todea CD; Duma VF; Sinescu C
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562600
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.
    Alrmali A; Saleh MHA; Kurdi SMS; Sabri H; Meghil MM; Wang HL
    Clin Exp Dent Res; 2023 Oct; 9(5):791-798. PubMed ID: 37605488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapies for MRONJ: A systematic review.
    Govaerts D; Piccart F; Ockerman A; Coropciuc R; Politis C; Jacobs R
    Bone; 2020 Dec; 141():115676. PubMed ID: 33022455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.
    Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU
    Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
    Anastasilakis AD; Pepe J; Napoli N; Palermo A; Magopoulos C; Khan AA; Zillikens MC; Body JJ
    J Clin Endocrinol Metab; 2022 Apr; 107(5):1441-1460. PubMed ID: 34922381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis.
    Momesso GAC; Lemos CAA; Santiago-Júnior JF; Faverani LP; Pellizzer EP
    Oral Maxillofac Surg; 2020 Jun; 24(2):133-144. PubMed ID: 32056052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study.
    Jamalpour MR; Shahabi S; Baghestani M; Shokri A; Jamshidi S; Khazaei S
    BMC Oral Health; 2022 Jun; 22(1):241. PubMed ID: 35717177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
    Hasegawa T; Kawakita A; Ueda N; Funahara R; Tachibana A; Kobayashi M; Kondou E; Takeda D; Kojima Y; Sato S; Yanamoto S; Komatsubara H; Umeda M; Kirita T; Kurita H; Shibuya Y; Komori T;
    Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of medication-related osteonecrosis of the jaw (MRONJ). A systematic review.
    Goker F; Grecchi E; Grecchi F; Francetti L; Del Fabbro M
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2662-2673. PubMed ID: 33829453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.